Bank Of New York Mellon Corp Gossamer Bio, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.96 - $2.92 $208,371 - $633,797	217,054 New	217,054 $273 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $384,254 - $2.84 Million	220,836 New	220,836 $479,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $536,784 - $1.11 Million	74,450 Added 38.6%	267,340 $3.2 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $209,744 - $350,276	-35,133 Reduced 15.41%	192,890 $1.62 Million
Q1 2022 May 11, 2022	SELL	$8.44 - $12.49 $1,460 - $2,160	-173 Reduced 0.08%	228,023 $1.98 Million
Q4 2021 Feb 11, 2022	SELL	$10.12 - $14.07 $60 - $84	-6 Reduced -0.0%	228,196 $2.58 Million
Q3 2021 Nov 12, 2021	BUY	$7.25 - $13.23 $128,064 - $233,694	17,664 Added 8.39%	228,202 $2.87 Million
Q2 2021 Aug 11, 2021	SELL	$8.0 - $9.75 $189,896 - $231,435	-23,737 Reduced 10.13%	210,538 $1.71 Million
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $22,075 - $27,984	-2,558 Reduced 1.08%	234,275 $2.17 Million
Q4 2020 Feb 09, 2021	BUY	$8.3 - $13.59 $88,395 - $144,733	10,650 Added 4.71%	236,833 $2.29 Million
Q3 2020 Nov 12, 2020	BUY	$11.3 - $14.75 $55,268 - $72,142	4,891 Added 2.21%	226,183 $2.81 Million
Q2 2020 Aug 12, 2020	BUY	$9.52 - $15.98 $437,072 - $733,657	45,911 Added 26.18%	221,292 $2.88 Million
Q1 2020 May 06, 2020	SELL	$8.0 - $15.48 $23,712 - $45,882	-2,964 Reduced 1.66%	175,381 $1.78 Million
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $241,076 - $435,792	16,267 Added 10.04%	178,345 $2.79 Million
Q3 2019 Nov 07, 2019	BUY	$16.02 - $22.47 $909,711 - $1.28 Million	56,786 Added 53.93%	162,078 $2.72 Million
Q2 2019 Aug 12, 2019	BUY	$16.12 - $22.89 $878,185 - $1.25 Million	54,478 Added 107.21%	105,292 $2.34 Million
Q1 2019 May 14, 2019	BUY	$17.58 - $23.97 $893,310 - $1.22 Million	50,814 New	50,814 $1.1 Million

Others Institutions Holding GOSS

# of Institutions

108

Shares Held

167M

Call Options Held

430K

Put Options Held

519K

Nea Management Company, LLC Timonium, MD

18.1M
Shares

$15.6 Million
1.37% of portfolio
Siren, L.L.C. New York, NY

13.3M
Shares

$11.4 Million
0.65% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$10.1 Million
0.0% of portfolio
Octagon Capital Advisors LP New York, NY

9.19M
Shares

$7.9 Million
2.2% of portfolio
Arch Venture Management, LLC Chicago, IL

8.06M
Shares

$6.93 Million
4.79% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account